Sarepta Therapeutics, Inc.
MX ˙ BMV ˙ US8036071004
SecurityMX:SRPT / Sarepta Therapeutics, Inc.
InstitutionWolverine Asset Management Llc
Latest Disclosed Ownership4,920 shares
Latest Disclosed Value $ 107,059
Wolverine Asset Management Llc ownership in SRPT / Sarepta Therapeutics, Inc.

On May 4, 2026 - Wolverine Asset Management Llc filed a 13F-HR form disclosing ownership of 4,920 shares of Sarepta Therapeutics, Inc. (MX:SRPT) valued at $107,059 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 14,237 shares of Sarepta Therapeutics, Inc.. This represents a change in shares of -65.44% during the quarter.

Wolverine Asset Management Llc has a history of taking positions in derivatives of the underlying security (SRPT) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 9,100 of underlying shares valued at $198,016 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:SRPT / Sarepta Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-04 2026-03-31 13F SAREPTA THERAPEUTICS COM 803607100 4,920 -9,317 -65.44 107 -65.03 0.0010
2026-02-02 2025-12-31 13F SAREPTA THERAPEUTICS COM 803607100 14,237 -11,949 -45.63 306 -39.29 0.0024
2025-10-28 2025-09-30 13F SAREPTA THERAPEUTICS COM 803607100 26,186 26,186 505 0.0037
2025-05-12 2025-03-31 13F SAREPTA THERAPEUTICS COM 803607100 0 -1,636 -100.00 0 -100.00
2025-02-03 2024-12-31 13F SAREPTA THERAPEUTICS COM 803607100 1,636 -3,676 -69.20 199 -70.14 0.0020
2024-11-04 2024-09-30 13F SAREPTA THERAPEUTICS COM 803607100 5,312 5,312 663 0.0071
2021-11-12 2021-09-30 13F SAREPTA THERAPEUTICS COM 803607100 0 -329 -100.00 0 -100.00
2021-08-13 2021-06-30 13F SAREPTA THERAPEUTICS COM 803607100 329 329 25 0.0002
2020-11-13 2020-09-30 13F SAREPTA THERAPEUTICS COM 803607100 0 -11 -100.00 0 -100.00
2020-08-13 2020-06-30 13F SAREPTA THERAPEUTICS COM 803607100 11 11 1 0.0000
2019-11-14 2019-09-30 13F SAREPTA THERAPEUTICS COM 803607100 0 -388 -100.00 0 -100.00
2019-08-14 2019-06-30 13F SAREPTA THERAPEUTICS COM 803607100 388 -11 -2.76 58 23.40 0.0008
2019-05-15 2019-03-31 13F SAREPTA THERAPEUTICS COM 803607100 399 399 2.84 47 -18.97 0.0006
2017-05-15 2017-03-31 13F SAREPTA THERAPEUTICS COM 803607100 0 -3,800 -100.00 0 -100.00
2017-02-13 2016-12-31 13F SAREPTA THERAPEUTICS COM 803607100 3,800 -100 -2.56 104 -56.49 0.0013
2016-11-14 2016-09-30 13F SAREPTA THERAPEUTICS COM 803607100 3,900 -29,600 -88.36 239 -70.31 0.0036
2014-05-14 2014-03-31 13F SAREPTA THERAPEUTICS COM 803607100 33,500 23,700 241.84 805 304.52 0.0172
2014-02-14 2013-12-31 13F SAREPTA THERAPEUTICS COM 803607100 9,800 9,800 199 0.0039
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2023-05-08 2023-03-31 13F SAREPTA THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-02-01 2022-12-31 13F SAREPTA THERAPEUTICS COM Call 9,100 0.00 1,179 17.31 n/a n/a n/a
2022-11-10 2022-09-30 13F SAREPTA THERAPEUTICS COM Call 9,100 1,005 n/a n/a n/a
2021-05-13 2021-03-31 13F SAREPTA THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-12 2020-12-31 13F SAREPTA THERAPEUTICS COM Call 3,300 562 n/a n/a n/a
2019-11-14 2019-09-30 13F SAREPTA THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-08-14 2019-06-30 13F SAREPTA THERAPEUTICS COM Call 6,100 0.00 926 27.37 n/a n/a n/a
2019-05-15 2019-03-31 13F SAREPTA THERAPEUTICS COM Call 6,100 0.00 727 -21.49 n/a n/a n/a
2018-05-15 2018-03-31 13F SAREPTA THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-02-14 2017-12-31 13F SAREPTA THERAPEUTICS COM Call 10,000 -24.24 556 -7.02 n/a n/a n/a
2017-11-14 2017-09-30 13F SAREPTA THERAPEUTICS COM Call 13,200 32.00 598 7.55 n/a n/a n/a
2017-08-14 2017-06-30 13F SAREPTA THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-05-15 2017-03-31 13F SAREPTA THERAPEUTICS COM Call 41,100 195,614.29 1,216 n/a n/a n/a
2014-02-14 2013-12-31 13F SAREPTA THERAPEUTICS COM Call 21 0.00 0 -100.00 n/a n/a n/a
2013-11-13 2013-09-30 13F SAREPTA THERAPEUTICS COM Call 21 5 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-04 2026-03-31 13F SAREPTA THERAPEUTICS COM Put 9,100 -53.57 198 -52.97 n/a n/a n/a
2026-02-02 2025-12-31 13F SAREPTA THERAPEUTICS COM Put 19,600 -49.35 422 -43.49 n/a n/a n/a
2025-10-28 2025-09-30 13F SAREPTA THERAPEUTICS COM Put 38,700 -39.25 746 -31.59 n/a n/a n/a
2025-08-04 2025-06-30 13F SAREPTA THERAPEUTICS COM Put 63,700 152.78 1,089 -32.28 n/a n/a n/a
2025-05-12 2025-03-31 13F SAREPTA THERAPEUTICS COM Put 25,200 -0.40 1,608 -47.72 n/a n/a n/a
2025-02-03 2024-12-31 13F SAREPTA THERAPEUTICS COM Put 25,300 0.00 3,076 -2.63 n/a n/a n/a
2024-11-04 2024-09-30 13F SAREPTA THERAPEUTICS COM Put 25,300 0.00 3,160 -20.97 n/a n/a n/a
2024-08-01 2024-06-30 13F SAREPTA THERAPEUTICS COM Put 25,300 0.00 3,997 22.05 n/a n/a n/a
2024-05-13 2024-03-31 13F SAREPTA THERAPEUTICS COM Put 25,300 -80.86 3,275 -74.31 n/a n/a n/a
2024-02-01 2023-12-31 13F SAREPTA THERAPEUTICS COM Put 132,200 0.15 12,748 -20.33 n/a n/a n/a
2023-11-13 2023-09-30 13F SAREPTA THERAPEUTICS COM Put 132,000 131,900.00 16,001 145,363.64 n/a n/a n/a
2023-08-07 2023-06-30 13F SAREPTA THERAPEUTICS COM Put 100 11 n/a n/a n/a
2023-05-08 2023-03-31 13F SAREPTA THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-02-01 2022-12-31 13F SAREPTA THERAPEUTICS COM Put 116,800 0.00 15,135 17.22 n/a n/a n/a
2022-11-10 2022-09-30 13F SAREPTA THERAPEUTICS COM Put 116,800 0.00 12,911 47.47 n/a n/a n/a
2022-08-03 2022-06-30 13F SAREPTA THERAPEUTICS COM Put 116,800 -46.13 8,755 -48.31 n/a n/a n/a
2022-05-04 2022-03-31 13F SAREPTA THERAPEUTICS COM Put 216,800 -11.94 16,936 -23.61 n/a n/a n/a
2022-02-09 2021-12-31 13F SAREPTA THERAPEUTICS COM Put 246,200 9.23 22,170 6.36 n/a n/a n/a
2021-11-12 2021-09-30 13F SAREPTA THERAPEUTICS COM Put 225,400 100.53 20,844 138.57 n/a n/a n/a
2021-08-13 2021-06-30 13F SAREPTA THERAPEUTICS COM Put 112,400 1,943.64 8,737 2,036.19 n/a n/a n/a
2021-05-13 2021-03-31 13F SAREPTA THERAPEUTICS COM Put 5,500 -71.94 409 -87.76 n/a n/a n/a
2021-02-12 2020-12-31 13F SAREPTA THERAPEUTICS COM Put 19,600 19.51 3,341 45.07 n/a n/a n/a
2020-11-13 2020-09-30 13F SAREPTA THERAPEUTICS COM Put 16,400 9.33 2,303 -4.24 n/a n/a n/a
2020-08-13 2020-06-30 13F SAREPTA THERAPEUTICS COM Put 15,000 0.00 2,405 63.94 n/a n/a n/a
2020-05-13 2020-03-31 13F SAREPTA THERAPEUTICS COM Put 15,000 -46.81 1,467 -59.68 n/a n/a n/a
2020-02-14 2019-12-31 13F SAREPTA THERAPEUTICS COM Put 28,200 -13.50 3,638 48.19 n/a n/a n/a
2019-11-14 2019-09-30 13F SAREPTA THERAPEUTICS COM Put 32,600 80.11 2,455 -10.73 n/a n/a n/a
2019-08-14 2019-06-30 13F SAREPTA THERAPEUTICS COM Put 18,100 311.36 2,750 424.81 n/a n/a n/a
2019-05-15 2019-03-31 13F SAREPTA THERAPEUTICS COM Put 4,400 41.94 524 55.03 n/a n/a n/a
2019-02-14 2018-12-31 13F SAREPTA THERAPEUTICS COM Put 3,100 0.00 338 -32.40 n/a n/a n/a
2018-11-14 2018-09-30 13F SAREPTA THERAPEUTICS COM Put 3,100 0.00 500 22.25 n/a n/a n/a
2018-08-14 2018-06-30 13F SAREPTA THERAPEUTICS COM Put 3,100 933.33 409 52.61 n/a n/a n/a
2014-05-14 2014-03-31 13F SAREPTA THERAPEUTICS COM Put 300 200.00 268 72.90 n/a n/a n/a
2014-02-14 2013-12-31 13F SAREPTA THERAPEUTICS COM Put 100 155 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.